<i>KCNT1</i>gain of function in 2 epilepsy phenotypes is reversed by quinidine

Abstract

These results establish direction for a targeted therapy and potentially exemplify a translational paradigm for in vitro studies informing novel therapies in a neuropsychiatric disease.